Liver International · 2021 · 11 citations · 9 references
PharmacyInfectious Disease ControlInfectious DiseasesInfectious Disease EpidemiologyMolecular VirologyVirologyAntiviral TherapyDisease ControlInterferon-based TherapyTreatmentViral HepatitisViral Hepatitis TreatmentAccess To TreatmentHepatitis C InfectionHepatitis C Virus ManagementHigh-risk Patient PopulationsHigh-risk Population PrevalencePopulation-wide Treatment CoverageTreatment Access PolicyViral Hepatitis Prevention
The WHO elimination goals (diagnosis of 90% of the cases of hepatitis C virus (HCV), treatment coverage in 80% and a 65% reduction in deaths from HCV) are set to be reached by 2030. Although these elimination programmes are extremely important in the Eastern European countries (Russia, Ukraine, Belarus and Moldova) with a high prevalence of HCV, limited economic resources prevent their development and implementation. Regardless of the decrease in the incidence HCV in all Eastern European countries, low diagnosis and treatment access, especially in high-risk populations, will not allow to achieve HCV elimination or even to control the infection by 2030.
9
Sadaf G Sepanlou, Saeid Safiri, Catherine Bisignano et al. · The Lancet. Gastroenterology & hepatology · 2020 · 1.7K citations · Full text
Adam Trickey, Hannah Fraser, Aaron G. Lim et al. · The Lancet. Gastroenterology & hepatology · 2019 · 247 citations · Full text